Monthly Archives: December 2021

US FDA approves Paxlovid   

  Btobioinnovation.com  Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com      SPECIAL REPORT #21.28                                 US FDA approves Paxlovid     On December 22, the U.S. FDA has given Pfizer’s Paxlovid an Emergency Use Approval (EUA) for the treatment of mild COVID-19, based on a study which showed the drug reduced […]

read more

Age Related Macular Degeneration.

  Btobioinnovation.com  Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com      SPECIAL REPORT #27     Age Related Macular Degeneration.       Age Related Macular Degeneration (AMD) is the major cause of irreversible central vision loss.  AMD is characterized by a progressive degeneration of the central zone of the retina: the macula. The fovea, […]

read more

Human Induced Pluripotent Stem Cells as Innovative Therapies

  Btobioinnovation.com  Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com      SPECIAL REPORT #21.26     Human Induced Pluripotent Stem Cells as Innovative Therapies     When, in 2007, Professor Shinya Yamanaka disclosed its discovery that mature human cells could be transformed into stem cells, better known now as human induced Pluripotent Stem Cells (hiPSC), […]

read more